The first attempt to impeach the homeland security secretary fell short by one vote, when he was not at the Capitol.
- Share full article
Representative Steve Scalise of Louisiana, the House majority leader, at the Capitol in November.
Representative Steve Scalise of Louisiana, the majority leader, returned to the Capitol on Tuesday following a six-week absence during which he received a stem-cell transplant as part of his treatment for blood cancer.
His Republican colleagues in the House were counting on his return to impeach Alejandro N. Mayorkas, the homeland security secretary, after a humiliating setback last week, when three Republicans joined all Democrats in rejecting the charges, leaving the G.O.P. just one vote short of a majority.
“I am back,” a smiling Mr. Scalise, mask in his hand, told a Fox News reporter as he re-entered the Capitol Tuesday afternoon. Mr. Scalise said he was feeling “great” and expressed confidence that the impeachment vote would move ahead as planned.
“To be back in person is really exciting,” he said. “I’ve heard the votes are tight; every vote is going to matter around here.”
Last week, after the stunning defeat of the first impeachment attempt, Republican leaders quickly said they would try again as soon as Mr. Scalise could return, potentially even the next day. That raised questions about whether the majority leader might place his health in grave danger to help Republicans press their case against Mr. Mayorkas, which is all but certain to die in the Democratic-led Senate.
But Mr. Scalise said Tuesday that after being in isolation for weeks as he received an autologous stem-cell transplant, he had been cleared by his doctors to travel.
We are having trouble retrieving the article content.
Please enable JavaScript in your browser settings.
Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.
Thank you for your patience while we verify access.
Already a subscriber? Log in.
Want all of The Times? Subscribe.
SKIP ADVERTISEMENT
Source: nytimes.com
